What You Should Know:
– Fangzhou Inc., a leader in Internet healthcare solutions announced a strategic collaboration with Novo Nordisk, a leading global healthcare company.
– The Memorandum of Understanding (MOU) was signed at the 3rd China International Supply Chain Expo in Beijing, signaling a joint effort to manage serious chronic diseases such as diabetes and obesity by leveraging Fangzhou’s AI application services, innovative treatment solutions, and convenient pharmaceutical services.
Comprehensive Health Management Through Smart Healthcare Ecosystem
By leveraging Novo Nordisk’s expertise and innovative products in diabetes and obesity treatment, Fangzhou plans to employ its smart healthcare ecosystem and robust technology infrastructure to create a comprehensive health management service. This service will include medication guidance, reminders, efficacy tracking, and health education, effectively shaping the value chain in the glucose control and weight loss sector. The partnership aims to shift the focus from a “disease-centered” approach to a “health-centered” model, providing patients with higher quality and more convenient one-stop healthcare services.
